Analysis Corporate cannabis continues value brand pivot as Canada enters recession The bulk value category is trending up as legal players compete with Canada's still-thriving unregulated market Jared GnamJune 5, 2020
Cannabis Tetra Bio-Pharma pens device deal with Storz & Bickel, Canopy Company says the deal is a crucial step in bringing its cancer pain treatment to market Nick LabaJune 5, 2020
Cannabis THC BioMed brings ‘true smoking alternative’ beverage shot to market The company says it's already completing orders in BC and Saskatchewan Nick LabaJune 4, 2020
COVID-19 Planet 13 says sales cut in half by COVID-19 Las Vegas company says adding 24-hour delivery helped relieve some pressure from pandemic-related tourism collapse Jared GnamJune 2, 2020
COVID-19 Canntab enters $1M purchase agreement with MediPharm The company says it has filed 13 patents in the US and Canada for its proprietary cannabis tablets Nick LabaJune 2, 2020
COVID-19 Auxly says record $10 million Q1 net revenue driven by cannabis 2.0 sales Company says infused candies and vapes made up 90% of first-quarter Canadian weed sales Jared GnamJune 1, 2020
Cannabis Valens enters into $40M secure credit facility The accordion loan can expand up to another $10 million Nick LabaJune 1, 2020
Cannabis 2.0 Canopy Growth shares sink after reporting another billion-dollar loss Company stock drops 20%, throws out previous profit targets for fiscal 2021 Jared GnamMay 29, 2020
The weed wire Tilray to shutter Ontario greenhouse as Canadian cannabis closures continue High Parks Gardens facility shutdown will save parent company $7.5 million annually while losing 120 workers Jared GnamMay 28, 2020
The weed wire EBITDA profitability a ‘transformational milestone’ for TerrAscend TerrAscend's strategy of focusing on US markets continue to pay off Nick LabaMay 28, 2020